From GlobeNewswire.: 2025-02-19 08:25:00

eXoZymes, Inc. announced that CEO Michael Heltzen and team members will ring the Nasdaq closing bell to celebrate their successful initial public offering at $8 per share. The company’s platform offers AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels. Exozymes, advanced enzymes enhanced with AI and bioengineering, can replace toxic petrochemical processes with sustainable biosolutions. The company believes that exozymes are the logical successor to most synthetic biology projects, ushering in the exozymes era of biotechnology. The company is not trademarking the concept of exozymes, viewing it as a new nomenclature for wide adoption.



Read more at GlobeNewswire.: eXoZymes Announces Nasdaq Bell Ringing to Commemorate